{"gene":"BRINP1","run_date":"2026-06-09T22:02:45","timeline":{"discoveries":[{"year":1998,"finding":"DBCCR1 (BRINP1) is silenced in bladder cancer cell lines via CpG island hypermethylation at its 5' region, as demonstrated by methylation analysis and de novo expression induction by a demethylating agent.","method":"Methylation analysis of CpG island; treatment with demethylating agent restoring expression","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal methods (methylation analysis + demethylating agent rescue), single lab","pmids":["9545632"],"is_preprint":false},{"year":2001,"finding":"Exogenous expression of DBCCR1 (BRINP1) in NIH3T3 cells and human bladder tumour cell lines suppresses proliferation by increasing the proportion of cells in G1 phase of the cell cycle, without altering apoptosis levels.","method":"Gene transfer (transient and stable transfection), cell cycle analysis by flow cytometry","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function in two cell line systems with defined cell-cycle phenotype, single lab","pmids":["11420708"],"is_preprint":false},{"year":2004,"finding":"DBCCR1 (BRINP1) protein expressed as an EGFP fusion in bladder tumour cells initially showed diffuse cytoplasmic localisation with nuclear exclusion, then redistributed to granular cytoplasmic structures coinciding with cell rounding and detachment. This DBCCR1-mediated cell death was independent of caspase-3 activation and did not produce detectable DNA strand breaks (TUNEL-negative), indicating a non-classical apoptotic mechanism.","method":"Transient transfection with DBCCR1-EGFP fusion; live-cell fluorescence imaging; caspase-3 assay; TUNEL staining","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localisation by fluorescent fusion protein with functional consequence, multiple assays, single lab","pmids":["14712213"],"is_preprint":false},{"year":2014,"finding":"Genetic ablation of BRINP1 in mice increases neurogenesis in the subgranular zone of the dentate gyrus, producing a more immature neuronal population in the granule cell layer, and increases the number of parvalbumin-expressing interneurons in hippocampal CA1, establishing BRINP1 as a suppressor of cell cycle progression in neural stem cells in vivo.","method":"BRINP1 knockout (KO) mouse generation; immunohistochemistry for neurogenesis markers and parvalbumin; behavioural phenotyping","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype (increased neurogenesis, altered interneuron numbers), single lab, multiple histological readouts","pmids":["24528488"],"is_preprint":false},{"year":2016,"finding":"Knockout of Brinp1 in mice increases the density of parvalbumin-expressing interneurons in the adult neocortex and alters expression of neuronal migration genes Astn1 and Astn2, indicating that BRINP1 influences cortical neuronal distribution during development.","method":"Cre-mediated Brinp1 knockout; immunohistochemistry; expression analysis of Astn1/Astn2","journal":"Molecular autism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype replicated across two independent KO studies, with expression analysis","pmids":["27042284"],"is_preprint":false},{"year":2017,"finding":"Restoration of DBCCR1 (BRINP1) expression in lung cancer cells inhibits growth, migration and invasion, while knockdown enhances these capacities. Additionally, DBCCR1 attenuates the expression of DNMT1, suggesting reciprocal regulation between DBCCR1 and DNA methylation machinery.","method":"siRNA knockdown; overexpression; proliferation, migration and invasion assays; DNMT1 expression analysis","journal":"Oncotarget","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, gain- and loss-of-function phenotypic assays with limited mechanistic detail on DNMT1 regulation","pmids":["28427182"],"is_preprint":false},{"year":2018,"finding":"BRINP1-KO mice show a ~50% reduction in parvalbumin-expressing neurons and ~20% reduction in somatostatin-expressing neurons in the medial prefrontal cortex, indicating that BRINP1 is required for normal GABAergic interneuron populations in the mPFC.","method":"Immunohistochemistry in BRINP1-KO vs wild-type mice","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with quantitative immunohistochemical phenotype, extends prior KO findings to a distinct brain region","pmids":["29960053"],"is_preprint":false}],"current_model":"BRINP1 (DBCCR1/FAM5A) is a neural-enriched protein that suppresses cell cycle progression in neural stem cells and negatively regulates the G1/S transition in tumour cells; its loss in mice increases hippocampal neurogenesis and disrupts cortical GABAergic interneuron (parvalbumin- and somatostatin-positive) populations, while in cancer contexts it is silenced by CpG island promoter hypermethylation and its re-expression causes non-classical, caspase-independent cell death with cytoplasmic-to-granular protein redistribution."},"narrative":{"mechanistic_narrative":"BRINP1 (DBCCR1/FAM5A) is a neural-enriched negative regulator of cell cycle progression that operates both in tumour suppression and in the control of neuronal production during brain development [PMID:11420708, PMID:24528488]. In tumour cells, exogenous BRINP1 restrains proliferation by increasing the fraction of cells held in G1 phase [PMID:11420708], and is silenced in bladder cancer through CpG island promoter hypermethylation, with expression restorable by demethylating agents [PMID:9545632]. Beyond growth arrest, re-expressed BRINP1 can trigger a non-classical, caspase-3-independent and TUNEL-negative form of cell death accompanied by redistribution of the protein from a diffuse cytoplasmic, nuclear-excluded pattern to granular cytoplasmic structures as cells round up and detach [PMID:14712213]. In vivo, genetic ablation of BRINP1 in mice increases neurogenesis in the dentate gyrus subgranular zone, yielding a more immature granule cell population, consistent with its role as a suppressor of neural stem cell cycle progression [PMID:24528488]. BRINP1 loss also disrupts cortical and hippocampal GABAergic interneuron populations, reducing parvalbumin- and somatostatin-expressing interneurons in the prefrontal cortex and altering neuronal migration gene expression (Astn1/Astn2) [PMID:27042284, PMID:29960053]. The biochemical activity by which BRINP1 imposes G1 arrest and the molecular basis of its granular redistribution and cell death have not been characterized in the available corpus.","teleology":[{"year":1998,"claim":"Establishing why BRINP1/DBCCR1 expression is lost in cancer: the gene is epigenetically silenced rather than mutated, marking it as a candidate tumour suppressor.","evidence":"CpG island methylation analysis and demethylating-agent rescue in bladder cancer cell lines","pmids":["9545632"],"confidence":"Medium","gaps":["Does not establish the functional consequence of silencing","No demonstration that re-expression alters tumour phenotype at this stage"]},{"year":2001,"claim":"Defining the cellular function behind tumour suppression: BRINP1 acts on the cell cycle, arresting cells in G1 rather than inducing death.","evidence":"Transient and stable transfection of DBCCR1 in NIH3T3 and bladder tumour cells with flow-cytometry cell-cycle analysis","pmids":["11420708"],"confidence":"Medium","gaps":["No molecular mechanism for G1 arrest identified","No interacting cell-cycle machinery defined"]},{"year":2004,"claim":"Characterizing an additional fate imposed by BRINP1 re-expression: a non-classical cell death distinct from canonical apoptosis, linked to protein redistribution.","evidence":"DBCCR1-EGFP live-cell imaging, caspase-3 assay, and TUNEL staining in bladder tumour cells","pmids":["14712213"],"confidence":"Medium","gaps":["The identity and composition of the granular structures are unknown","Death pathway not molecularly defined","Apparent discrepancy with the earlier non-apoptotic G1-arrest phenotype not reconciled"]},{"year":2014,"claim":"Extending BRINP1's cell-cycle role from tumour cells to physiology: it suppresses neural stem cell proliferation in vivo and shapes interneuron populations.","evidence":"BRINP1 knockout mouse with immunohistochemistry for neurogenesis and parvalbumin markers and behavioural phenotyping","pmids":["24528488"],"confidence":"Medium","gaps":["Molecular pathway linking BRINP1 loss to increased neurogenesis unknown","Whether interneuron changes are cell-autonomous not established"]},{"year":2016,"claim":"Linking BRINP1 to neuronal positioning: its loss alters cortical interneuron density and migration-gene expression, implicating it in developmental neuronal distribution.","evidence":"Cre-mediated Brinp1 knockout with immunohistochemistry and Astn1/Astn2 expression analysis","pmids":["27042284"],"confidence":"Medium","gaps":["Mechanistic connection between BRINP1 and Astn1/Astn2 regulation unresolved","Direct vs indirect effect on migration not distinguished"]},{"year":2017,"claim":"Generalizing tumour suppression beyond bladder and probing a feedback loop: BRINP1 limits growth/migration/invasion in lung cancer and dampens DNMT1.","evidence":"siRNA knockdown and overexpression with proliferation/migration/invasion assays and DNMT1 expression analysis in lung cancer cells","pmids":["28427182"],"confidence":"Low","gaps":["Mechanism of DNMT1 attenuation not defined and not independently confirmed","Reciprocal methylation regulation remains correlative"]},{"year":2018,"claim":"Refining the regional specificity of BRINP1's developmental role: it is required for normal parvalbumin and somatostatin interneuron numbers in the prefrontal cortex.","evidence":"Quantitative immunohistochemistry in BRINP1-KO versus wild-type mouse medial prefrontal cortex","pmids":["29960053"],"confidence":"Medium","gaps":["Does not establish whether interneuron loss reflects altered production, migration, or survival","Molecular effector remains unidentified"]},{"year":null,"claim":"The biochemical activity of BRINP1 remains undefined: how it imposes G1 arrest, what molecular partners mediate its action, and the mechanism of its granular redistribution and caspase-independent death are unknown.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No enzymatic activity or direct binding partner identified","No structural model","Mechanism connecting cytoplasmic localization to cell-cycle and death control unresolved"]}],"mechanism_profile":{"molecular_activity":[],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,3]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O60477","full_name":"BMP/retinoic acid-inducible neural-specific protein 1","aliases":["Deleted in bladder cancer protein 1"],"length_aa":761,"mass_kda":88.8,"function":"Plays a role in neurogenesis and brain development (By similarity). May suppress cell cycle progression in postmitotic neurons by inhibiting G1/S transition (PubMed:11420708)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O60477/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BRINP1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BRINP1","total_profiled":1310},"omim":[{"mim_id":"619359","title":"BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 2; BRINP2","url":"https://www.omim.org/entry/619359"},{"mim_id":"618390","title":"BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 3; BRINP3","url":"https://www.omim.org/entry/618390"},{"mim_id":"602865","title":"BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 1; BRINP1","url":"https://www.omim.org/entry/602865"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Microtubules","reliability":"Uncertain"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":37.8}],"url":"https://www.proteinatlas.org/search/BRINP1"},"hgnc":{"alias_symbol":["FAM5A"],"prev_symbol":["DBCCR1","DBC1"]},"alphafold":{"accession":"O60477","domains":[{"cath_id":"-","chopping":"46-203_210-268","consensus_level":"high","plddt":81.6604,"start":46,"end":268},{"cath_id":"-","chopping":"279-438","consensus_level":"medium","plddt":87.4211,"start":279,"end":438},{"cath_id":"2.60.120.260","chopping":"484-622_647-662","consensus_level":"high","plddt":83.4967,"start":484,"end":662},{"cath_id":"-","chopping":"665-758","consensus_level":"high","plddt":81.6031,"start":665,"end":758}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60477","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60477-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60477-F1-predicted_aligned_error_v6.png","plddt_mean":77.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BRINP1","jax_strain_url":"https://www.jax.org/strain/search?query=BRINP1"},"sequence":{"accession":"O60477","fasta_url":"https://rest.uniprot.org/uniprotkb/O60477.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60477/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60477"}},"corpus_meta":[{"pmid":"9545632","id":"PMC_9545632","title":"Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9545632","citation_count":118,"is_preprint":false},{"pmid":"11420708","id":"PMC_11420708","title":"Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11420708","citation_count":50,"is_preprint":false},{"pmid":"27777512","id":"PMC_27777512","title":"Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer.","date":"2016","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/27777512","citation_count":45,"is_preprint":false},{"pmid":"24528488","id":"PMC_24528488","title":"Absence of BRINP1 in mice causes increase of hippocampal neurogenesis and behavioral alterations relevant to human psychiatric disorders.","date":"2014","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/24528488","citation_count":39,"is_preprint":false},{"pmid":"27042284","id":"PMC_27042284","title":"Brinp1(-/-) mice exhibit autism-like behaviour, altered memory, hyperactivity and increased parvalbumin-positive cortical interneuron density.","date":"2016","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/27042284","citation_count":36,"is_preprint":false},{"pmid":"14712213","id":"PMC_14712213","title":"DBCCR1 mediates death in cultured bladder tumor cells.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14712213","citation_count":28,"is_preprint":false},{"pmid":"15226771","id":"PMC_15226771","title":"Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma.","date":"2004","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15226771","citation_count":22,"is_preprint":false},{"pmid":"29960053","id":"PMC_29960053","title":"Decreased parvalbumin and somatostatin neurons in medial prefrontal cortex in BRINP1-KO mice.","date":"2018","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/29960053","citation_count":17,"is_preprint":false},{"pmid":"15643521","id":"PMC_15643521","title":"Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma.","date":"2005","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/15643521","citation_count":13,"is_preprint":false},{"pmid":"34267256","id":"PMC_34267256","title":"The conserved ASTN2/BRINP1 locus at 9q33.1-33.2 is associated with major psychiatric disorders in a large pedigree from Southern Spain.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34267256","citation_count":7,"is_preprint":false},{"pmid":"28427182","id":"PMC_28427182","title":"Identification of DBCCR1 as a suppressor in the development of lung cancer that is associated with increased DNA methyltransferase 1.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28427182","citation_count":4,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7619,"output_tokens":1661,"usd":0.023886,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8457,"output_tokens":2408,"usd":0.051243,"stage2_stop_reason":"end_turn"},"total_usd":0.075129,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"DBCCR1 (BRINP1) is silenced in bladder cancer cell lines via CpG island hypermethylation at its 5' region, as demonstrated by methylation analysis and de novo expression induction by a demethylating agent.\",\n      \"method\": \"Methylation analysis of CpG island; treatment with demethylating agent restoring expression\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal methods (methylation analysis + demethylating agent rescue), single lab\",\n      \"pmids\": [\"9545632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Exogenous expression of DBCCR1 (BRINP1) in NIH3T3 cells and human bladder tumour cell lines suppresses proliferation by increasing the proportion of cells in G1 phase of the cell cycle, without altering apoptosis levels.\",\n      \"method\": \"Gene transfer (transient and stable transfection), cell cycle analysis by flow cytometry\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function in two cell line systems with defined cell-cycle phenotype, single lab\",\n      \"pmids\": [\"11420708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DBCCR1 (BRINP1) protein expressed as an EGFP fusion in bladder tumour cells initially showed diffuse cytoplasmic localisation with nuclear exclusion, then redistributed to granular cytoplasmic structures coinciding with cell rounding and detachment. This DBCCR1-mediated cell death was independent of caspase-3 activation and did not produce detectable DNA strand breaks (TUNEL-negative), indicating a non-classical apoptotic mechanism.\",\n      \"method\": \"Transient transfection with DBCCR1-EGFP fusion; live-cell fluorescence imaging; caspase-3 assay; TUNEL staining\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localisation by fluorescent fusion protein with functional consequence, multiple assays, single lab\",\n      \"pmids\": [\"14712213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Genetic ablation of BRINP1 in mice increases neurogenesis in the subgranular zone of the dentate gyrus, producing a more immature neuronal population in the granule cell layer, and increases the number of parvalbumin-expressing interneurons in hippocampal CA1, establishing BRINP1 as a suppressor of cell cycle progression in neural stem cells in vivo.\",\n      \"method\": \"BRINP1 knockout (KO) mouse generation; immunohistochemistry for neurogenesis markers and parvalbumin; behavioural phenotyping\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype (increased neurogenesis, altered interneuron numbers), single lab, multiple histological readouts\",\n      \"pmids\": [\"24528488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Knockout of Brinp1 in mice increases the density of parvalbumin-expressing interneurons in the adult neocortex and alters expression of neuronal migration genes Astn1 and Astn2, indicating that BRINP1 influences cortical neuronal distribution during development.\",\n      \"method\": \"Cre-mediated Brinp1 knockout; immunohistochemistry; expression analysis of Astn1/Astn2\",\n      \"journal\": \"Molecular autism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype replicated across two independent KO studies, with expression analysis\",\n      \"pmids\": [\"27042284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Restoration of DBCCR1 (BRINP1) expression in lung cancer cells inhibits growth, migration and invasion, while knockdown enhances these capacities. Additionally, DBCCR1 attenuates the expression of DNMT1, suggesting reciprocal regulation between DBCCR1 and DNA methylation machinery.\",\n      \"method\": \"siRNA knockdown; overexpression; proliferation, migration and invasion assays; DNMT1 expression analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, gain- and loss-of-function phenotypic assays with limited mechanistic detail on DNMT1 regulation\",\n      \"pmids\": [\"28427182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BRINP1-KO mice show a ~50% reduction in parvalbumin-expressing neurons and ~20% reduction in somatostatin-expressing neurons in the medial prefrontal cortex, indicating that BRINP1 is required for normal GABAergic interneuron populations in the mPFC.\",\n      \"method\": \"Immunohistochemistry in BRINP1-KO vs wild-type mice\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with quantitative immunohistochemical phenotype, extends prior KO findings to a distinct brain region\",\n      \"pmids\": [\"29960053\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BRINP1 (DBCCR1/FAM5A) is a neural-enriched protein that suppresses cell cycle progression in neural stem cells and negatively regulates the G1/S transition in tumour cells; its loss in mice increases hippocampal neurogenesis and disrupts cortical GABAergic interneuron (parvalbumin- and somatostatin-positive) populations, while in cancer contexts it is silenced by CpG island promoter hypermethylation and its re-expression causes non-classical, caspase-independent cell death with cytoplasmic-to-granular protein redistribution.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BRINP1 (DBCCR1/FAM5A) is a neural-enriched negative regulator of cell cycle progression that operates both in tumour suppression and in the control of neuronal production during brain development [#1, #3]. In tumour cells, exogenous BRINP1 restrains proliferation by increasing the fraction of cells held in G1 phase [#1], and is silenced in bladder cancer through CpG island promoter hypermethylation, with expression restorable by demethylating agents [#0]. Beyond growth arrest, re-expressed BRINP1 can trigger a non-classical, caspase-3-independent and TUNEL-negative form of cell death accompanied by redistribution of the protein from a diffuse cytoplasmic, nuclear-excluded pattern to granular cytoplasmic structures as cells round up and detach [#2]. In vivo, genetic ablation of BRINP1 in mice increases neurogenesis in the dentate gyrus subgranular zone, yielding a more immature granule cell population, consistent with its role as a suppressor of neural stem cell cycle progression [#3]. BRINP1 loss also disrupts cortical and hippocampal GABAergic interneuron populations, reducing parvalbumin- and somatostatin-expressing interneurons in the prefrontal cortex and altering neuronal migration gene expression (Astn1/Astn2) [#4, #6]. The biochemical activity by which BRINP1 imposes G1 arrest and the molecular basis of its granular redistribution and cell death have not been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing why BRINP1/DBCCR1 expression is lost in cancer: the gene is epigenetically silenced rather than mutated, marking it as a candidate tumour suppressor.\",\n      \"evidence\": \"CpG island methylation analysis and demethylating-agent rescue in bladder cancer cell lines\",\n      \"pmids\": [\"9545632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish the functional consequence of silencing\", \"No demonstration that re-expression alters tumour phenotype at this stage\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defining the cellular function behind tumour suppression: BRINP1 acts on the cell cycle, arresting cells in G1 rather than inducing death.\",\n      \"evidence\": \"Transient and stable transfection of DBCCR1 in NIH3T3 and bladder tumour cells with flow-cytometry cell-cycle analysis\",\n      \"pmids\": [\"11420708\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No molecular mechanism for G1 arrest identified\", \"No interacting cell-cycle machinery defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Characterizing an additional fate imposed by BRINP1 re-expression: a non-classical cell death distinct from canonical apoptosis, linked to protein redistribution.\",\n      \"evidence\": \"DBCCR1-EGFP live-cell imaging, caspase-3 assay, and TUNEL staining in bladder tumour cells\",\n      \"pmids\": [\"14712213\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The identity and composition of the granular structures are unknown\", \"Death pathway not molecularly defined\", \"Apparent discrepancy with the earlier non-apoptotic G1-arrest phenotype not reconciled\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extending BRINP1's cell-cycle role from tumour cells to physiology: it suppresses neural stem cell proliferation in vivo and shapes interneuron populations.\",\n      \"evidence\": \"BRINP1 knockout mouse with immunohistochemistry for neurogenesis and parvalbumin markers and behavioural phenotyping\",\n      \"pmids\": [\"24528488\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular pathway linking BRINP1 loss to increased neurogenesis unknown\", \"Whether interneuron changes are cell-autonomous not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linking BRINP1 to neuronal positioning: its loss alters cortical interneuron density and migration-gene expression, implicating it in developmental neuronal distribution.\",\n      \"evidence\": \"Cre-mediated Brinp1 knockout with immunohistochemistry and Astn1/Astn2 expression analysis\",\n      \"pmids\": [\"27042284\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic connection between BRINP1 and Astn1/Astn2 regulation unresolved\", \"Direct vs indirect effect on migration not distinguished\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Generalizing tumour suppression beyond bladder and probing a feedback loop: BRINP1 limits growth/migration/invasion in lung cancer and dampens DNMT1.\",\n      \"evidence\": \"siRNA knockdown and overexpression with proliferation/migration/invasion assays and DNMT1 expression analysis in lung cancer cells\",\n      \"pmids\": [\"28427182\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanism of DNMT1 attenuation not defined and not independently confirmed\", \"Reciprocal methylation regulation remains correlative\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Refining the regional specificity of BRINP1's developmental role: it is required for normal parvalbumin and somatostatin interneuron numbers in the prefrontal cortex.\",\n      \"evidence\": \"Quantitative immunohistochemistry in BRINP1-KO versus wild-type mouse medial prefrontal cortex\",\n      \"pmids\": [\"29960053\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not establish whether interneuron loss reflects altered production, migration, or survival\", \"Molecular effector remains unidentified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The biochemical activity of BRINP1 remains undefined: how it imposes G1 arrest, what molecular partners mediate its action, and the mechanism of its granular redistribution and caspase-independent death are unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No enzymatic activity or direct binding partner identified\", \"No structural model\", \"Mechanism connecting cytoplasmic localization to cell-cycle and death control unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}